News + Filings Transactions Holdings
All 13F 13D/G Other
|
Gao Hanlin
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/21/2023 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.
Txns:
| Sold 342 shares
@ $33.8811, valued at
$11.6k
|
|
08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2023 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.
Txns:
| Sold 1,000 shares
@ $40.2961, valued at
$40.3k
|
|
06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/19/2023 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.
Txns:
| Sold 345 shares
@ $35.4623, valued at
$12.2k
|
|
05/02/2023 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.
Txns:
| Paid exercise price by delivering 76 shares
@ $29.57, valued at
$2.2k
|
|
02/27/2023 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.
Txns:
| Granted 2,142 shares
@ $0 Granted 12,156 shares
@ $0 Paid exercise price by delivering 794 shares
@ $31.65, valued at
$25.1k
|
|
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/18/2022 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.
Txns:
| Sold 342 shares
@ $35.8906, valued at
$12.3k
|
|
08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/17/2022 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.
Txns:
| Paid exercise price by delivering 303 shares
@ $66.49, valued at
$20.1k
|
|
11/18/2021 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.
Txns:
| Sold 311 shares
@ $95.5021, valued at
$29.7k
|
|
08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/18/2020 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.
Txns:
| Sold 301 shares
@ $45.4488, valued at
$13.7k
|
|
09/17/2020 |
SC 13D/A
| Gao Hanlin reports a 3.6% stake in Fulgent Genetics, Inc. |
09/15/2020 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.
Txns:
| Disposed of 467,659 shares
@ $0 |
|
08/19/2020 |
4
| Gao Hanlin (Chief Scientific Officer) has filed a Form 4 on Fulgent Genetics, Inc.
Txns:
| Sold 1,308 shares
@ $41.1098, valued at
$53.8k
|
|
09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/13/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/11/2016 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
10/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/28/2016 |
3
| Gao Hanlin (Chief Scientific Officer) has filed a Form 3 on Fulgent Genetics, Inc. |
|
|